Abstract These studies were designed to determine the possible role of platelet-activating factor (PAF) in the production of monocyte chemoattractant protein-l (MCP-l) in glomerular immune injury. The glomerular lesion was induced in isolated perfused rat kidneys by a rabbit anti-rat-thymocyte serum (ATS) and rat serum (RS) as a complement source. Perfusion of kidneys with ATS and RS results in the selective binding of the antiserum to the glomerular mesangium with consecutive intraglomerular activation of complement. Antibody binding and complement activation induced a significant increase in glomerular MCP-l mRNA levels when assessed by Northern blotting or RT-PCR. Decomplemented RS or non antibody rabbit IgG had only moderate effects on glomerular MCP-l mRNA levels. The PAF receptor antagonist WEB 2170 almost completely blocked the ATS and RS induced MCP-l mRNA levels. Perfusion of control kidneys with PAF increased MCP-l mRNA expression, an effect which was blocked by WEB 2170. Glomerular MCP-l protein formation, assessed by Western blotting, was stimulated following ATS and RS and PAF, respectively, was blocked by WEB 2170. These data show that PAF, derived from glomerular resident cells following antibody and complement induced injury, stimulates MCP-l expression. In addition to the direct effects on leukocyte adhesion and activation PAF may mediate inflammatory cell influx in glomerular injuries due to the release of MCP-l.
Introduction
PAF is a mediator of inflammation. It exerts a variety of biologic actions among which its effects on renal hemodynamic changes and inflammatory cell recruitment are of particular importance in glomerular immune injury [1, 2] . In glomerulonephritis PAF formation is increased. The production ofPAF in renal disease depends on intraglomerular antibody binding, complement activation and platelet influx [3] . The role of PAF in the pathophysiology of glomerulonephritis was characterized by the use of various PAF receptor blockers. Blocking PAF activity improves glomerular hemodynamic function and proteinuria and it reduces the infiltration of inflammatory cells [4] [5] [6] [7] . The mechanisms by which PAF is involved in the recruitment of glomerular inflammatory cells in immune injury may include the immune complex mediated release of PAF by glomerular resident cells and consecutive direct effects on adhesion and migration of PMNs, eosinophils and monocytesjmacrophages (MjM) [8] [9] [10] . PAF, however, is also a potent amplifier of leukocyte responses and initiates the formation of proinflammatory cytokines, such as interleukin-If (lL-lfj) and tumor necrosis factor (TNF). Induction of these cytokines may aggravate an inflammatory process in the glomerulus by mechanisms not entirely defined and not solely related to direct effects of PAF on inflammatory cells [11] .
Recent studies in several animal models of glomerulonephritis demonstrate that the glomerular inflammatory cell recruitment can also be ameliorated by approaches, which are directed to reduce the formation or function of chemokines [12] [13] [14] [15] , a group of small cytokines which exert strong chemoattractant activities on inflammatory leukocytes [16] .
In the animal model of anti-thymocyte antibodyinduced glomerular injury we recently found increased glomerular formation of the -C-C-chemokine MCP-l [15, 17] . In the same animal model the PAF-receptor antagonist WEB 2170 ameliorates the infiltration of leukocytes into glomeruli [7] . These findings in the ATS model may suggest that the action of PAF and MCP-l might be interrelated. In order to address this issue and to avoid the possible influence of inflammatory leukocytes in glomeruli, which are capable of producing both PAF and MCP-l, a recently developed model of immune injury in the isolated perfused kidney was applied [18] . Our experiments show that antibody and complement induce glomerular MCP-l mRNA and protein expression. The increase in glomerular MCP-l formation can be blocked by the PAF-receptor antagonist WEB 2170. These data demonstrate that PAF is a mediator of MCP-l formation in this ex vivo model of glomerular injury. In addition to its direct effects on inflammatory cells it might participate in glomerular injury by the stimulation of MCP-l.
Methods

Kidney perfusion
Rat kidneys were derived from male Wistar rats (body weight 220-250 g). Animals were anesthethized by i.p. injection of pentobarbital sodium (60 mg/kg b.w.). They were placed on heated operating tables (37°C) and the abdomen was opened. After ligation of intraphrenical arteries the right kidney was removed and weighed. The aorta was opened and a catheter (PP 50 tubing, Portex, Hythe, UK) was advanced to the origin of the left renal artery. The perfusion was started and the aorta was ligated above the renal artery. The renal vein was opened to allow perfusate flow and the kidney was transferred into a heated organ bath (38°C). The venous effiuate left the organ bath through an overflow device and urine was collected by an indvelling ureter catheter. Experiments were performed at a constant pressure (100 mmHg) and temperature (38°C). The perfusion system consisted of a heated perfusate reservoir containing v--21 of a cell free perfusion fluid, which was pregassed with oxygen. Perfusion pressure was generated by a peristaltic pump (Gilson, Langenfeld, Germany) and regulated by an adjustable tubing in a water-filled column. The perfusate was permanently oxygenated during the experiments (Enka Labormodul, Wuppertal, Germany). Perfusion pressure was monitored using Statham pressure transducers P 23 (Gould, Oxnard, CA, USA). After an equilibration period of 10 min, experiments were started and glomeruli were harvested at 50 and 60 min following the application of the antibody (for details see [18] ). Urine was collected over 60 min.
Perfusate
The perfusate was a modified Krebs-Henseleit solution which contained (all data as mM if not stated otherwise): sodium 145, potassium 5.0, chloride 110, magnesium 1.0, calcium 1.0, hydrogencarbonate 27.4, hydrogenphosphate 0.66, dihydrogenphosphate 0.3, glucose 7.6, urea 6.0, inulin 200 mg/l (Merck, Darmstadt, Germany), Glutamine 0.4 (Sigma Chemicals, Munich, Germany), Amino Acids (Aminoplasmal paed. 5%, Braun, Melsungen, Germany) 22 mljl. A gelatine preparation was used as a colloidosmotic agent (Haemaccel, Behringwerke, Marburg, Germany) at a concentration of 35 gil. The solution was filtered through a 0.45 urn cellulose acetate filter prior to the experiment (Sartorius, Gottingen, Germany).
xperimentalgroups Glomerular immune injury in the isolated perfused rat kidneys was induced by the application of a rabbit antithymocyte antiserum (ATS) (300 ul antiserum in 5 ml perfusate) which was given within 1 min. ATS was followed by
2 ml of rat serum which served as complement source. This procedure induces an injury which is characterized by selective binding of antibody to the mesangium with complement activation and a reduction in perfusate flow rate and in GFR. The induction of this lesion is dependent on the antibody binding and the complement activation [18] . This injury does not induce lysis of the mesangial cells in the IPK. The following groups were studied (number of experiments in brackets). Group 1. Controls. Kidneys were perfused with control solution (n=8). Group 2. To study the effect of ATS and RS, kidneys were perfused as described above with antibody and rat serum (n=6). Group 3. To study the role of complement, kidneys were perfused with ATS and heat inactivated rat serum (n = 5). Group 4. The specificity of the antibody was studied by perfusion with non-antibody rabbit IgG and RS (n = 5). Group 5. To test the effect of endogenously formed PAF on glomerular MCP-l expression, kidneys were perfused with the PAF receptor antagonist WEB 2170 (1 gil) following the application of ATS and RS (n = 5). Group 6. In order to test the effect of WEB 2170 on MCP-l expression, kidneys were perfused with WEB 2170 alone (1 gil) (n=4). Group 7. To study the effect of PAF, kidneys were perfused with PAF (500~g/l) (n=5). Group 8. Kidneys were perfused with PAF (500~g/l) and WEB 2170 (1 gil) to test the specificity of the PAF effect (n=4). Group 9. Since PAF can induce renal prostaglandin formation, which can inhibit MCP-l expression [15] , kidneys were co-perfused with PAF and the cyclooxygenase inhibitor indomethacin (10 mg/l perfusate) (n = 5). Group 10. The role of endogenous cyclooxygenase products on MCP-l expression was evaluated by perfusion with Indomethacin (10 mg/l ) (n = 5).
Isolation ofglomerular RNA, Northern blotting, and RT-PCRfor MCP-l
Glomeruli were isolated from all perfused kidneys at the end of the experiment by fractional sieving according to a technique described earlier [19] . The purity of the glomerular preparation reached 95%. Cellular RNA from whole glomeruli was isolated by the guanidine isothiocyanate method [20] .
For Northern blots 20 ug RNA was electrophoresed through a 1.2% agarose gel, containing 2.2 M formaldehyde. Equal loading of lanes was evaluated by ethidium bromide staining of the 18S and 28S rRNA. The RNA was transferred to nylon membranes (Zetabind; Cuno, Meriden, CT) by vacuum blotting and ultraviolet crosslinked. The blots were hybridized with a cDNA probe for rat MCP-l after [ 32 P]dCTP-labeling by random oligonucleotide priming of the cDNA insert (420 bp EcoRl fragment) [21] . The membranes were washed to a final high stringency in 0.1 x SSPE/O.5% sodium dodecyl sulfate (1 x SSPE=0.18 M NaCl/lOmM sodium phosphate, pH 7.4/1 mM EDTA) for 30-60 min at 65°C. Autoradiography was performed with the intensifying screen at -70°C for appropriate time periods. The size of the respective RNA was identified by comparison of its mobility with the ethidium bromide-stained RNA standards. The membranes were rehybridized with a cDNA probe encoding for the genes GAPDH or 18S rRNA, respectively, to account for small loading and transfer variations. Exposed films were scanned with a laser densitometer (Hoefer Scientific Instruments, San Francisco, CA) and relative RNA levels were calculated.
For RT-PCR 5 J.1g of RNA in 7.5 J. 11 H 2 0 were incubated at 6SOC for 3 min to untie secondary RNA structure. To minimize differences between the tubes, a Master Mix containing 5.5 J.11 First Strand Buffer (250 mM Tris-HCl, 375 mM KCl, 15 mM MgCI 2 ) , 3.4 J. 11 dNTPs (2.5 mM each), 2.7 J.11 DTT (0.1 M), 0.5 J.1g Poly dT Primer (Pharmacia, Freiburg, Germany), 14 U RNAsin (Promega, Madison, WI, USA) and 200 U M-MLV reverse transcriptase (Gibco BRL, Eggenstein, Germany) per sample was prepared and added to each sample in equal quantity. The RT reaction was carried out for 90 min at 37°C. To perform PCR the following sequence was used based on the following rat eDNA: sense primer: 5'ACA GTT GCT GCC TGT AGC AT 3'; antisense primer: 5'CAC ACT AGT TCT CTG TCA TAC 3' (produced with Oligo 1000 NA Synthesizer, Beckman, Munich, Germany). To 5 J. 11 of each sample 18.2 J. 11 H 2 0 , 2.5 J. 11 10 x PCR-buffer, 500 mM KCl, 100 mM Tris-HCl, 1% Triton X100, 1.5 J. 11 of an internal standard, or H 2 0 , respectively (PCR MIMIC, Clontech, Palo Alto, CA, USA), and 0.5 U Taq DNA Polymerase (Promega) were added. The standard concentrations used ranged between 0.01 and 0.1 pgjJ.1l. Rat MCP-l standard was prepared using the sense primer 5'ACA GTT GCT GCC TGT AGC AT CGC AAG TGA AAT CTC CTC CG 3' and the antisense primer 5'CAC ACT AGT TCT CTG TCA TAC TTG AGT CCA TGG GGA GCT TT 3' (MCP-l specific parts of the primers underlined). The primers were annealed to a BamHljEcoRI v-erb B fragment according to the Mimic Kit protocol. The v-erb B fragment was used to avoid interference with the rat MCP-l eDNA. The resulting 580 bp fragment had annealing sites for the same rat MCP-l primers used for the amplification of the native MCP-l fragment derived from glomerular RNA. To correct for transfer variations and quality differences of RNA and RT, an additional PCR for rat GAPDH was run using the following eDNA: sense primer 5'AAT GCA TCC TGC ACC ACC AA 3'; antisense primer 5'GTA GCC ATA TTC CAT TGT CAT A 3' encoding for a 520 bp fragment. PCR was run for 28 cycles using the following temperature profile: denaturation at 95°C for 10 s, annealing for 20 s at 57°C, extension for 40 s at n°c. Finally an extension step for 5 min at 72°C was performed (GAPDH not shown to avoid presentation of redundant data). Each sample was evaluated with different standard concentrations. 10 J.11 of each reaction cup were run on a 1.5% agarose gel which contained 1 mgjml ethidiumbromide and photographed on UV light using a Polaroid 655 film. Photographs were analysed by densitometry with a HSI densitometer and absorption was calculated with Quick Integration Algorithm of the program GS 365W (Hoefer Scientific Instruments, San Francisco, CA, USA). With this approach a standard curve between the PCR-product and the number of cycles is obtained which shows linearity [15] . Additionally an RT-PCR was performed using constant amounts of eDNA derived from PAF-perfused kidneys (as described above) and different standard concentrations (0.01-0.05) to demonstrate the competitive nature of this PCR technique.
Immunoblotting for MCP-l
Isolated glomeruli were dissolved in 100 J.11 of Lammli buffer and boiled for 10 min. The non soluble material was separated by centrifugation. Together with a rat MCP-l standard (l00 ng) (IC Chemicals, Haar, Germany) proteins were separated on an 8% SDSjpolyacrylamide gel. The separated 39 proteins were transferred electrophoretically to a polyvinyl membrane. Blocking was performed in 5% non-fat dry milk prepared in PBS containing 0.1% Tween 20. MCP-l protein was identified immunochemically by incubating the membrane with a rabbit anti rat MCP-l antiserum (1 :250 dilution) and horseradish peroxidase conjugated goat anti-rabbit IgG. The signal was developed with a luminescence immunodetection assay (ECL Western blotting system, Amersham).
Histology
Renal tissue from animals or isolated perfused kidneys was obtained from all kidneys and was assessed for ATS and complement C3. The tissues were fixed in 4% buffered formaldehyde. To study ATS and rat C3 binding in kidneys, paraffin embedded tissue sections were stained with a goat antibody directed against rabbit IgG (Dakopatts, Hamburg, Germany) and a mouse monoclonal antibody against rat C3. The antibodies were developed using the alkaline phosphatase anti-alkaline phosphatase (APAAP) technique.
Statistical analysis
Results are expressed as means ±SD. Statistical significance was defined as P < 0.05. To compare two distinct treatment groups, the Mann-Whitney test was applied. For comparison of different groups the Kruskall-Wallis rank test was used.
Results
Histology
Immunohistologic staining of ATS and rat serum perfused kidneys showed selective binding of the antibody to the glomerular mesangium, when stained with an antibody to rabbit IgG. In rats perfused with ATS and rat serum staining with an antibody to rat C3 also showed positivity, selectivity in the glomerular mesangium. Perfusion of kidneys with WEB 2170 did not affect antibody binding or C3 activation in the glomerulus, when assessed by immunohistology. (These data are not presented since the findings are identical to the histologies shown in [15] and [18] ).
Glomerular MCP-l mRNA expression
Earlier studies in this model revealed that after 50 min the MCP-l expression was maximal in this model [15] . Therefore the studies were carried out over 50 or 60 min. When analysed by Northern blotting, kidneys which were perfused with ATS and RS demonstrated expression of MCP-l mRNA (Figure 1) , whereas MCP-l mRNA was undetectable in control perfused kidneys. When kidneys were perfused with antibody and heat inactivated RS or non antibody rabbit IgG and RS the mRNA expression was only moderately increased. These data show that antibody and complement are necessary to induce MCP-l mRNA expression. The coperfusion of ATS +RS with the PAFreceptor antagonist WEB 2170 almost completely blocked the glomerular MCP-l mRNA expression. No effect on glomerular mRNA was seen, when the kidneys were perfused with WEB 2170 (Figure 2 ). Since the yield of total RNA from glomeruli of isolated perfused kidneys varies from experiment to experiment and the amount is sometimes not sufficient for Northern blotting, we applied RT-PCR to quantitate the glomerular mRNA expression for all consecutive experiments. The evaluation of the PCR technique showed that the amplification of eDNA and standard fragment in the same reaction cup was competitive, thus allowing a quantitative analysis (Figure 3) . When analysed by RT-PCR the glomerular expression of MCP-1 mRNA in kidneys which were perfused with ATS +RS was markedly increased (4.5-fold by densitometry) compared with control perfused kidneys ( Figure 4 ) and confirmed the data obtained by Northern blotting. Control kidneys, however, also revealed expression ofMCP-l, which demonstrates the enhanced sensitivity of this assay system compared with the Northern blots . The co-perfusion of the kidneys with the PAF-receptor-antagonist WEB 2170 (which was applied in 1% ethanol) reduced glomerular MCP-l mRNA expression below control levels, indicating that the basal expression of MCP-1 is also reduced by WEB 2170. A 1% ethanol solution, which served as a carrier of WEB 2170 had no effect on ATS + RS induced chemokine expression (Figure 4) .
In order to test whether PAF per se induces glomerular MCP-1 expression, kidneys were perfused with PAF over 50 min. PAF induced a 2.5-fold increase in glomerular MCP-1 expression, an effect which was completely blunted when PAF was co-perfused with WEB 2170 ( Figure 5 ). The perfusion of kidneys with PAF induced only~50% of the stimulating effect on MCP-1 mRNA seen with ATS and RS. Since PAF is a known stimulator of glomerular prostaglandin E2 formation [22] , which suppresses glomerular and mesangial cell MCP-1 formation [15, 23] , the effect of the cyclooxygenase inhibitor indomethacin on PAF-induced MCP-1 expression was studied. Compared with controls, the perfusion of kidneys with indomethacin increased the mRNA expression of MCP-l ( Figure 6 ).
Discussion
Glomerular MCP-l protein
When assessed by Western blotting no MCP-l protein was detected in lysed glomeruli of control kidneys (Figure 7) . Glomeruli of kidneys perfused with antibody and rat serum showed a strong signal corresponding to the recombinant rat MCP-I . When the kidneys were perfused with WEB 2170 glomerular MCP-1 protein formation was markedly reduced, when compared with the glomeruli of the kidneys with the immune injury. Perfusion with PAF resulted in an increased formation of MCP-I as determined by Western blotting (Figure 8 ).
The regulation of chemokine formation in glomerular resident cells is an important step in the development of antibody induced glomerulonephritis, since chemokines might mediate adhesion and infiltration of inflammatory cells on the glomerular level and thereby participate in the induction and progression of disease [2] . The present study provides evidence that in glomeruli of the isolated perfused kidney following immune injury, PAF is a mediator ofMCP-1 mRNA expression and consecutive protein secretion. The perfusion of kidneys with anti-thymocyte antibody followed by rat serum induces expression of glomerular MCP-I mRNA. There was only a moderate increase in glomerular MCP-I mRNA expression following antibody and heat inactivated rat serum as well as with non-antibody IgG and rat serum. The expression of MCP-I is dependent on the specificity of the antibody and the intraglomerular complement activation, an observation which was made earlier in the in vivo model of this disease [17] . The PAF receptor blocker WEB 2170 almost completely ameliorated this antibody and complement stimulated MCP-I expression. In order to test the specificity of the WEB 2170 induced effects, kidneys were perfused with PAF and with PAF and WEB 2170. PAF induced a 2.S-fold increase in MCP-I mRNA expression compared with controls , however, this effect was less, compared with ATS and RS. The specificity of the PAF effect was demonstrated by the blocking effect of WEB 2170 on MCP-I expression. The somewhat less pronounced effect of PAF on MCP-I expression might be due to its ability to stimulate renal prostaglandin formation [22] . Since PGE2 is a suppressor of MCP-I formation in mesangial cells [23] and glomeruli [IS], endogenously formed prostanoids might ameliorate the PAF effects. This was demonstrated in experiments, which reveal that the cyclooxygenase inhibitor increased the PAF induced expression of glomerular MCP-l. Our studies further demonstrate, that in the IPK MCP-I formation under control conditions is also mediated by cyclooxygenase products since indomethacin enhances MCP-I expression by 2.S-fold ( Figure 6 ). These data therefore suggest an important role of cyclooxygenase products in the regulation of MCP-I which is probably not solely induced by PAF. The experiments with indomethacin, however, do not define which cyclooxygenase products are mediating the suppressor effect on MCP-l. Since, in glomerular mesangial cells PGE2 is the major metabolite induced by PAF this prostaglandin might be a primary candidate. In order to test whether the increased mRNA levels of MCP-I also result in changes of protein formation, we assessed the MCP-I protein synthesis of the glomeruli by Western blotting. In control kidneys, no MCP-I (Figure 7) or very low expression of this protein (Figure 8 ) was detected. This shows that there are small variations between different perfusion experiments. However, antibody and RS or perfusion with PAF, respectively, always strongly stimulated MCP-I formation when compared to the basal MCP-I expression in controls. MCP-l protein synthesis was almost completely blocked, when the kidneys were coperfused with the PAF receptor blocker. These data strongly support the mRNA data and show that antibody and RS induced effects on MCP-I formation are mediated by PAF.
In summary, these data demonstrate that PAF is a mediator of glomerular MCP-l expression in antibody and complement induced injury in this model of the isolated perfused kidney. The experiments furthermore supply evidence for a repressive role of endogenously formed cyclooxygenase products on MCP-l formation. The effect of PAF might be relevant in the chemokine mediated recruitment of inflammatory cells in glomerulonephritis. ..
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